journal
Journals CA: a Cancer Journal for Clini...

CA: a Cancer Journal for Clinicians

https://read.qxmd.com/read/37358310/survival-outcomes-used-to-validate-version-9-of-the-american-joint-committee-on-cancer-staging-system-for-appendiceal-cancer
#21
REVIEW
Lauren M Janczewski, Amanda E Browner, Joseph H Cotler, Heidi Nelson, Sanjay Kakar, Norman J Carr, Nader N Hanna, Andreana N Holowatyj, Richard M Goldberg, M Kay Washington, Elliot A Asare, Michael J Overman
The standard for cancer staging in the United States for all cancer sites, including primary carcinomas of the appendix, is the American Joint Committee on Cancer (AJCC) staging system. AJCC staging criteria undergo periodic revisions, led by a panel of site-specific experts, to maintain contemporary staging definitions through the evaluation of new evidence. Since its last revision, the AJCC has restructured its processes to include prospectively collected data because large data sets have become increasingly robust and available over time...
June 26, 2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/36869429/cancer-survivors-at-greater-risk-for-bone-fractures-late-in-life
#22
JOURNAL ARTICLE
Mike Fillon
No abstract text is available yet for this article.
March 2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/36869428/near-majority-of-adults-favor-r-ratings-for-films-with-smoking
#23
JOURNAL ARTICLE
Mike Fillon
No abstract text is available yet for this article.
March 2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/36305841/consensuses-controversies-and-future-directions-in-treatment-deintensification-for-human-papillomavirus-associated-oropharyngeal-cancer
#24
REVIEW
Jung Julie Kang, Yao Yu, Linda Chen, Kaveh Zakeri, Daphna Yael Gelblum, Sean Matthew McBride, Nadeem Riaz, C Jillian Tsai, Anuja Kriplani, Tony K W Hung, James V Fetten, Lara A Dunn, Alan L Ho, Jay O Boyle, Ian S Ganly, Bhuvanesh Singh, Eric J Sherman, David G Pfister, Richard J Wong, Nancy Y Lee
The most common cancer caused by human papillomavirus (HPV) infection in the United States is oropharyngeal cancer (OPC), and its incidence has been rising since the turn of the century. Because of substantial long-term morbidities with chemoradiation and the favorable prognosis of HPV-positive OPC, identifying the optimal deintensification strategy for this group has been a keystone of academic head-and-neck surgery, radiation oncology, and medical oncology for over the past decade. However, the first generation of randomized chemotherapy deintensification trials failed to change the standard of care, triggering concern over the feasibility of de-escalation...
March 2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/36260350/advances-in-the-treatment-of-intrahepatic-cholangiocarcinoma-an-overview-of-the-current-and%C3%A2-future%C3%A2-therapeutic-landscape-for-clinicians
#25
REVIEW
Dimitrios Moris, Manisha Palta, Charles Kim, Peter J Allen, Michael A Morse, Michael E Lidsky
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and remains a fatal malignancy in the majority of patients. Approximately 20%-30% of patients are eligible for resection, which is considered the only potentially curative treatment; and, after resection, a median survival of 53 months has been reported when sequenced with adjuvant capecitabine. For the 70%-80% of patients who present with locally unresectable or distant metastatic disease, systemic therapy may delay progression, but survival remains limited to approximately 1 year...
March 2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/36149820/prevention-of-device-related-infections-in-patients-with-cancer-current-practice-and-future-horizons
#26
REVIEW
George M Viola, Ariel D Szvalb, Alexandre E Malek, Anne-Marie Chaftari, Ray Hachem, Issam I Raad
Over the past several years, multifaceted advances in the management of cancer have led to a significant improvement in survival rates. Throughout patients' oncological journeys, they will likely receive one or more implantable devices for the administration of fluids and medications as well as management of various comorbidities and complications related to cancer therapy. Infections associated with these devices are frequent and complex, often necessitating device removal, increasing health care costs, negatively affecting quality of life, and complicating oncological care, usually leading to delays in further life-saving cancer therapy...
March 2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37924523/to-lower-cancer-risks-study-shows-that-food-choices-matter
#27
COMMENT
Mike Fillon
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37924522/mced-blood-test-boosts-cancer-detection-in-symptomatic-patients
#28
JOURNAL ARTICLE
Mike Fillon
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37665330/adding-immunotherapy-to-chemotherapy-improves-survival-for-endometrial-cancer-patients
#29
COMMENT
Mike Fillon
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37665329/study-identifies-signs-and-symptoms-of-colorectal-cancer-risk-at-younger-ages
#30
JOURNAL ARTICLE
Mike Fillon
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37490348/the-evolving-landscape-of-salivary-gland-tumors
#31
REVIEW
Conor E Steuer, Glenn J Hanna, Kartik Viswanathan, James E Bates, Azeem S Kaka, Nicole C Schmitt, Alan L Ho, Nabil F Saba
Salivary gland cancers are a rare, histologically diverse group of tumors. They range from indolent to aggressive and can cause significant morbidity and mortality. Surgical resection remains the mainstay of treatment, but radiation and systemic therapy are also critical parts of the care paradigm. Given the rarity and heterogeneity of these cancers, they are best managed in a multidisciplinary program. In this review, the authors highlight standards of care as well as exciting new research for salivary gland cancers that will strive for better patient outcomes...
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37395562/clinicians-need-to-stay-current-with-polypharmacy-concerns
#32
COMMENT
Mike Fillon
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37395561/does-distance-deter-male-fertility-preservation
#33
COMMENT
Mike Fillon
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37358050/isn-t-there-enough-evidence-on-the-benefits-of-patient-navigation
#34
EDITORIAL
Electra D Paskett, Tracy Battaglia, Elizabeth A Calhoun, Michelle C Chappell, Andrea Dwyer, Linda G Fleisher, Jennifer Greenwald, Kristen J Wells
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37358040/patient-navigation-across-the-cancer-care-continuum-an-overview-of-systematic-reviews-and-emerging-literature
#35
REVIEW
Raymond J Chan, Vivienne E Milch, Fiona Crawford-Williams, Oluwaseyifunmi Andi Agbejule, Ria Joseph, Jolyn Johal, Narayanee Dick, Matthew P Wallen, Julie Ratcliffe, Anupriya Agarwal, Larissa Nekhlyudov, Matthew Tieu, Manaf Al-Momani, Scott Turnbull, Rahul Sathiaraj, Dorothy Keefe, Nicolas H Hart
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022...
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37347977/implementation-in-action-collaborating-on-the-transition-to-primary-hpv-screening-for-cervical-cancer-in-the-united-states
#36
JOURNAL ARTICLE
Levi S Downs, Ritu Nayar, Jane Gerndt, Debbie Saslow
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37329269/clinical-insights-into-small-cell-lung-cancer-tumor-heterogeneity-diagnosis-therapy-and-future-directions
#37
REVIEW
Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, Robert Pirker, Gyula Ostoros, Simon Heeke, Christian Lang, Konrad Hoetzenecker, Anna Schwendenwein, Kristiina Boettiger, Paul A Bunn, Ferenc Renyi-Vamos, Karin Schelch, Helmut Prosch, Lauren A Byers, Fred R Hirsch, Balazs Dome
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity. It has strong epidemiologic and biologic links to tobacco carcinogens. Although the majority of SCLCs exhibit neuroendocrine features, an important subset of tumors lacks these properties. Genomic profiling of SCLC reveals genetic instability, almost universal inactivation of the tumor suppressor genes TP53 and RB1, and a high mutation burden. Because of early metastasis, only a small fraction of patients are amenable to curative-intent lung resection, and these individuals require adjuvant platinum-etoposide chemotherapy...
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37329257/social-determinants-of-health-and-us-cancer-screening-interventions-a-systematic-review
#38
REVIEW
Ariella R Korn, Callie Walsh-Bailey, Margarita Correa-Mendez, Peter DelNero, Meagan Pilar, Brittney Sandler, Ross C Brownson, Karen M Emmons, April Y Oh
There remains a need to synthesize linkages between social determinants of health (SDOH) and cancer screening to reduce persistent inequities contributing to the US cancer burden. The authors conducted a systematic review of US-based breast, cervical, colorectal, and lung cancer screening intervention studies to summarize how SDOH have been considered in interventions and relationships between SDOH and screening. Five databases were searched for peer-reviewed research articles published in English between 2010 and 2021...
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37314110/virtual-tumor-board-papillary-thyroid-carcinoma-with-nodal-disease
#39
JOURNAL ARTICLE
Peter J Abraham, Rongzhi Wang, Deepti Bahl, Pradeep Bhambhvani, Sadie Ho, Jessica M Fazendin, Herbert Chen, Brenessa M Lindeman
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/37226418/multidisciplinary-approach-for-a-high-risk-localized-soft-tissue-sarcoma-of-the-trunk-after-unplanned-nononcological-resection
#40
JOURNAL ARTICLE
Candace L Haddox, Elizabeth H Baldini, Jyothi P Jagannathan, Jason L Hornick, Chandrajit P Raut
No abstract text is available yet for this article.
2023: CA: a Cancer Journal for Clinicians
journal
journal
20065
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.